U.S. Life Sciences Stock News

If you are wondering whether Vail Resorts is attractively priced after a long slide in the share price, this article walks through what the current valuation might be telling you. The stock last closed at US$138.53, with returns of 1.6% over 7 days, a 1.8% decline over 30 days, a 3.4% gain year to date, and declines of 9.2%, 26.2% and 47.5% over the past 1, 3 and 5 years respectively. Recent news coverage has focused on Vail Resorts as a large operator in the ski and mountain resort space,...

Stock performance snapshot and recent context Qiagen (QGEN) has seen its share price under pressure recently, with a 4.2% one day decline and negative returns over the past week, month, and past 3 months. This may prompt investors to reassess the setup. See our latest analysis for Qiagen. That 4.2% one day share price decline fits into a weaker recent pattern, with a 30 day share price return of 18.85% and a year to date share price return of a 13.37% decline, even though the 1 year total...

Recent performance snapshot Coinbase Global (COIN) has seen mixed share performance recently, with a 1 day gain of 1.1% and a 3.9% decline over the past week, alongside a reported last close of US$198.63. Over the past month the stock shows a 22.2% return, while the past 3 months reflect a 25.7% decline and the year to date return stands at a 16.0% decline. See our latest analysis for Coinbase Global. At the current share price of US$198.63, Coinbase Global’s recent 22.2% 1 month share price...

Recent performance context for Synopsys (SNPS) Without a specific news catalyst, Synopsys (SNPS) has still been on many investors' radars, given its recent share performance and its role supplying design and IP tools to the semiconductor and electronics industries. See our latest analysis for Synopsys. At a share price of US$432.98, Synopsys has seen its 90 day share price return of 9.28% and year to date share price return of 9.87% contrast with a 5 year total shareholder return of 83.77%...

Wondering whether CarGurus at around US$31.39 is still offering value, or if most of the opportunity has already been priced in? This article is built to help you answer that question. The stock has been choppy recently, with a 6.4% decline over the last week, a 10.1% gain over the last 30 days, and returns of 0.7% over 1 year, 80.4% over 3 years, and 20.7% over 5 years. These swings come as investors continue to reassess online auto platforms more broadly and react to ongoing sentiment...

If you are wondering whether Clorox is fairly priced or offering value at today's levels, its recent share performance gives you a useful starting point. The stock last closed at US$112.15, with a 7 day return of a 4.5% decline, a 30 day return of a 6.2% decline, and a year to date gain of 11.2%, against a 1 year return of a 20.8% decline and a 5 year return of a 30.3% decline. Recent coverage around Clorox has focused on its role as a well known consumer staples name and how it fits into...

ASP Isotopes (ASPI) is drawing fresh attention after subsidiary Quantum Leap Energy signed a non binding MOU with a major U.S. nuclear operator to explore support for U.S. based advanced fuel cycle facilities. See our latest analysis for ASP Isotopes. The MOU headlines arrive after a mixed year for ASP Isotopes, with the latest share price at $5.68, a 7 day share price return of 11.15% and a 1 year total shareholder return of 44.9%. This suggests that recent optimism is building on already...

Recent Performance Snapshot Griffon (GFF) shares have come under pressure recently, with the stock down about 1.5% on the day, 9.3% over the past week, and roughly 22% over the past month. Over the past 3 months the decline is closer to 4%. The stock still shows an 8.5% total return over the past year and a very large gain over 3 and 5 years. See our latest analysis for Griffon. With the share price now at $74.15, Griffon’s short term share price momentum has cooled, even as the 1 year total...

If you are wondering whether Ligand Pharmaceuticals at US$221.24 is still offering value after a big run, you are not alone. That is exactly what this article will unpack. The stock has returned 5.9% over the last 7 days, 18.4% over the last 30 days, 16.4% year to date, 104.7% over 1 year and 209.0% over 3 years, with a 5 year return of 106.6%. Recent headlines around Ligand Pharmaceuticals have focused on its role in the pharmaceuticals and biotech space and how the market is reassessing...

How Analog Devices Stock Has Been Performing Recently Analog Devices (ADI) has seen mixed share price moves recently, with a small 0.1% gain over the past day, a 6.5% decline across the past week, and a modest slide over the past month. Looking a bit further back, the stock is up about 12.6% over the past 3 months, with total returns of 16.6% year to date and 56.9% over the past year, and 1.26x over five years. See our latest analysis for Analog Devices. Recent weakness in the 7 day and 30...

Curious whether PennyMac Financial Services at around US$87.65 is a bargain or a value trap right now? This article walks through the numbers so you can judge for yourself. The stock has seen a 3.3% decline over the past 7 days and a 7.6% decline over the past 30 days, while still sitting on a 60.8% return over 3 years and 40.6% over 5 years. These figures can change how investors think about both risk and opportunity. Recent coverage has focused on how mortgage and housing market conditions...

IBM and Lam Research recently announced a five-year collaboration to co-develop materials, etch and deposition processes, and High NA EUV lithography for sub-1nm logic scaling, leveraging IBM’s Albany NanoTech facilities and Lam’s Aether dry resist, Kiyo and Akara etch platforms, and Striker and ALTUS Halo deposition systems. This agreement deepens a decade-long partnership and positions Lam at the center of research aimed at extending Moore’s Law into complex nanosheet, nanostack, and...

In early March 2026, Antero Resources reported fourth-quarter 2025 results that exceeded expectations, highlighting the completed acquisition of HG Energy, which added meaningful acreage, drilling locations, and extended the company’s core inventory life. This combination of stronger operations, a longer inventory runway, and an emphasis on dry-gas exposure and efficiencies has also drawn continued attention from research analysts reassessing Antero’s business outlook. We’ll now examine...

If you are wondering whether Nuvalent at around US$100 a share still offers fair value, you are not alone. This article is built to help you make sense of the current price tag. The stock is roughly flat year to date with a 0.8% decline, but over the last year it has returned 38.0%, and over three years the return is very large. That performance can change how investors think about both upside and risk. Recent headlines around Nuvalent have focused on its progress as a clinical stage...

The European Commission Joint Research Centre has awarded an Amentum-led joint venture a US$112 million framework contract to decommission and manage radioactive waste at nuclear research sites in Italy, Germany, Belgium and the Netherlands, covering reactors, hot cells, accelerators and other contaminated infrastructure over an initial two-year term with potential extensions. This win underscores Amentum’s role in complex nuclear decommissioning and could be important for its roughly 17%...

MP Materials (MP) is back in focus after a series of government backed moves, including a US$400 million Pentagon investment for a 15% stake and a 10 year rare earth supply agreement. See our latest analysis for MP Materials. After these government backed moves and the 10X Texas project, MP’s share price has had a steady year to date with a 13.24% share price return. The 1 year total shareholder return of 155.75% points to strong longer term momentum. If this rare earth story has your...

United Natural Foods, Inc. reported second-quarter 2026 results showing sales of US$7.95 billion versus US$8.16 billion a year earlier, but moved from a small loss to a US$20 million profit and completed a US$87.73 million buyback covering 4.41% of its shares. The company raised its full-year net income and EPS guidance while trimming its sales outlook, signaling that efficiency gains and margin improvement are currently more influential for earnings than top-line growth. We’ll now examine...

Recursion Pharmaceuticals (RXRX) has drawn fresh attention after reporting Q4 revenue above consensus, highlighting progress in its AI-native drug discovery platform and a cash runway that management says extends into early 2028. See our latest analysis for Recursion Pharmaceuticals. Despite the strong Q4 update and progress across its AI-native programs, Recursion Pharmaceuticals’ share price return has been weak, with a 30 day share price return decline of 10.39% and a 1 year total...

Terreno Realty Corporation recently renewed early a lease on a 2.8-acre improved land parcel and secured a new lease on an adjacent 2.3-acre parcel in Gardena, California through August 2029, while also selling a fully leased 56,000-square-foot industrial property in Lanham, Maryland for approximately US$11.1 million on March 6, 2026. Together, these transactions highlight Terreno Realty’s active approach to recycling capital and extending industrial land tenancy in key coastal logistics...

In its fiscal second quarter ended January 31, 2026, Uranium Energy Corp. reported sales of US$20.2 million, a net loss of US$13.94 million, and loss per share of US$0.03, alongside a sharp year-on-year revenue drop. Despite lower sales and continued losses, the company highlighted a debt-free balance sheet, strong liquidity, uranium sales priced well above quarterly averages, and completion of the Burke Hollow ISR uranium mine as a new U.S. production asset. With that context, we’ll now...

Director at Lincoln Educational Services (NasdaqGS:LINC) recently executed a sizable share sale, extending a pattern of insider selling. Recent filings show continued insider disposals over time, with no offsetting insider purchases reported. The cluster of sales focuses attention on board sentiment and governance signals that are not visible in headline financials. Lincoln Educational Services, listed on the NasdaqGS under the ticker LINC, operates career-focused education programs that...

Earlier this week, Goodyear Tire & Rubber faced higher input and operating cost pressures as Brent crude oil prices climbed above US$110 per barrel amid renewed Middle East conflict and risks to vital shipping routes like the Strait of Hormuz. This shock to energy and logistics costs hits a manufacturer heavily exposed to petroleum-based materials, adding another layer of expense risk to an already cost-sensitive tire business. Next, we’ll examine how this jump in oil-driven cost pressures...

What the latest ARES-G3 launch and earnings beat mean for Waters (WAT) Waters (WAT) just rolled out its ARES-G3 Rheometer while also reporting fourth quarter results that topped expectations and came with positive sales and earnings guidance for the next few quarters. See our latest analysis for Waters. Even with the ARES-G3 launch and an earnings beat in the background, Waters’ share price has been under pressure, with a 30 day share price return of 9.33% decline and a 1 year total...

If you are wondering whether Victory Capital Holdings is still reasonably priced after its run in recent years, you are not alone. This article is built to help you frame that question clearly. The stock last closed at US$67.69, with returns of 5.6% year to date and 21.8% over the past year. The past 3 and 5 years have produced very large gains of roughly 7x and just under 3x respectively, alongside recent 7 day and 30 day declines of 1.5% and 8.8%. Recent news around asset managers like...